Zobrazeno 1 - 10
of 108
pro vyhledávání: '"I. Font-Noguera"'
Autor:
J.L. Poveda Andrés, R Mendez Ocaña, E Lopez Britz, O Ballesta Lopez, JA Román Ivorra, R Menendez Villanueva, I. Font Noguera, C Borras Almenar, T Palanques Pastor, R Iglesias Gómez
Publikováno v:
Section 6: Education and research.
Background and importance Baricitinib has recently been used off-label for COVID-19 because of its potential role in reducing systemic inflammation, lung damage, immune response and viral endocytosis based on preclinical data Aim and objectives To an
Autor:
P Pérez Huertas, I. Font Noguera, M Martín Cerezuela, C Borras Almenar, M. J. Fernández Megía, R Luna Reina, J.L. Poveda Andrés
Publikováno v:
Eur J Hosp Pharm
Background The pharmaceutical care programmes are effective strategies to improve the health outcomes in chronic patients, particularly in solid organ transplant patients, due to the complexity of immunosuppressive therapy. The pharmaceutical care co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::632ab950477ff1ed2b9c90f80c4301be
https://europepmc.org/articles/PMC7535288/
https://europepmc.org/articles/PMC7535288/
Autor:
R. Dolz-Marco, Isabel Pascual-Camps, Roberto Gallego-Pinazo, José Luis Poveda-Andrés, J. Ruiz Ramos, M.A. Fenoll, I. Font-Noguera, M.J. Cuéllar-Monreal
Publikováno v:
Archivos de la Sociedad Española de Oftalmología. 90:566-571
Resumen Objetivo El objetivo de este estudio es analizar la efectividad, seguridad y costes de aflibercept en el tratamiento de la degeneracion macular relacionada con la edad (DMAE) refractaria al ranibizumab. Metodos Estudio observacional retrospec
Autor:
Roberto Gallego-Pinazo, José Luis Poveda-Andrés, I. Font-Noguera, J. Ruiz Ramos, M.J. Cuéllar-Monreal, M.A. Fenoll, R. Dolz-Marco, Isabel Pascual-Camps
Publikováno v:
Archivos de la Sociedad Española de Oftalmología (English Edition). 90:566-571
Purpose The aim of this study is to determine the effectiveness, safety and cost of aflibercept in the treatment of wet age-related macular degeneration (ARMD) refractory to ranibizumab. Methods Retrospective observational study was conducted on pati
Autor:
L. Doménech-Moral, I. Font-Noguera, V. Bosó-Ribelles, P. Romero-Boyero, José Luis Poveda-Andrés, M. Pérez-Cebrián
Publikováno v:
Farmacia Hospitalaria (English Edition). 35:180-188
Objective To assess the efficacy of a new quality control strategy based on daily randomised sampling and monitoring of a sentinel surveillance system (SSS) medication cart, in order to identify medication errors and their origin at different levels
Autor:
José Luis Poveda-Andrés, V. Bosó-Ribelles, P. Romero-Boyero, L. Doménech-Moral, I. Font-Noguera, M. Pérez-Cebrián
Publikováno v:
Farmacia Hospitalaria. 35:180-188
Resumen Objetivo Analizar la eficacia de una nueva estrategia de control de calidad basada en el muestreo aleatorio y seguimiento de carros de dispensacion de dosis unitaria (carro centinela) para identificar los errores en las distintas fases del pr
Publikováno v:
Farmacia Hospitalaria. 35:75-79
Objective: Assessing the effectiveness and safety of natalizumab for treating relapsingremitting multiple sclerosis in a tertiary hospital. Method: Observational, prospective study of adult patients treated with natalizumab from May 2007 until Februa
Publikováno v:
Farmacia Hospitalaria (English Edition). 35:75-79
Objective Assessing the effectiveness and safety of natalizumab for treating relapsing-remitting multiple sclerosis in a tertiary hospital. Method Observational, prospective study of adult patients treated with natalizumab from May 2007 until Februar
Autor:
M. Montero Hernández, L. Doménech Moral, I. Font Noguera, J.L. Poveda Andrés, V. Merino Sanjuán, J. Hernández Martín
Publikováno v:
Farmacia Hospitalaria. 34:1-8
Introduction: The objective is to assess a pharmaceutical care programme for heart transplant patients upon patient admission and discharge. Material y methods: Observational study of heart transplant patients, performed during the first quarter of 2
Autor:
I. Font Noguera, J.L. Poveda Andrés, M. Montero Hernández, V. Merino Sanjuán, L. Doménech Moral, J. Hernández Martín
Publikováno v:
Farmacia Hospitalaria (English Edition). 34:1-8
Introduction The objective is to assess a pharmaceutical care programme for heart transplant patients upon patient admission and discharge. Material and methods Observational study of heart transplant patients, performed during the first quarter of 2